EUVIMEDOpdag EUVIMED
Fallbericht

Salvage Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplant With Posttransplant Cyclophosphamide for Graft Failure in a Patient With Chronic Active Epstein-Barr Virus Infection

Yosuke Nakaya, Hideo Koh, Naonori Harada, Hiroshi Okamura, Takuya Misugi, Tomoki Suekane, Daisuke Tachibana, Hiroshi Kimura, Masayuki Hino, Hirohisa Nakamae

Experimental and Clinical Transplantation · 2023

DOI: 10.6002/ect.2022.0322 ↗

At a glance

Fallbericht in Experimental and Clinical Transplantation, 2023. Written by Yosuke Nakaya and 9 co-authors. Institution: From the Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Major MEDLINE topics: Hematopoietic Stem Cell Transplantation, Epstein-Barr Virus Infections, Graft vs Host Disease. 51 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Salvage human leukocyte antigen-haploidentical hematopoietic cell transplant using posttransplant cyclophosphamide has shown promising results for graft failure in various hematological disorders. However, to our knowledge, no such findings have been reported for a case of chronic active Epstein-Barr virus infection, although graft failure is relatively common in patients with chronic active Epstein-Barr virus infection. We report a case of a 32-year-old woman with natural killer-cell type chronic active Epstein-Barr virus infection who experienced graft failure after a first allogeneic hematopoietic cell transplant from an unrelated human leukocyte antigen-matched donor.The patientreceived a second allogeneic hematopoietic cell transplant with human leukocyte antigen-haploidentical hematopoietic cell transplant using posttransplant cyclophosphamide (cyclophosphamide, 50 mg/kg, on day 3 and day 4) following reduced-intensity conditioning as rescue therapy. Neutrophils successfully engrafted on day 19, and the patient sustained remission without severe transplant-related complication 10 months after salvage human leukocyte antigen- haploidentical hematopoietic cell transplant using posttransplant cyclophosphamide. This report suggests that salvage human leukocyte antigen- haploidentical hematopoietic cell transplant using posttransplant cyclophosphamide may be a feasible therapeutic option for graft failure in patients with chronic active Epstein-Barr virus infection.

Subjects

MeSH terms (MEDLINE)

Hematopoietic Stem Cell TransplantationEpstein-Barr Virus InfectionsGraft vs Host DiseaseFemaleHumansAdultHerpesvirus 4, HumanCyclophosphamideHLA AntigensTransplantation Conditioning

Substances

CyclophosphamideHLA Antigens

Authors and institutions

  • From the Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Cite

APA

Nakaya, Y., Koh, H., Harada, N., Okamura, H., Misugi, T., Suekane, T., Tachibana, D., Kimura, H., Hino, M., & Nakamae, H. (2023). Salvage Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplant With Posttransplant Cyclophosphamide for Graft Failure in a Patient With Chronic Active Epstein-Barr Virus Infection. Experimental and Clinical Transplantation. https://doi.org/10.6002/ect.2022.0322

Vancouver

Nakaya Y, Koh H, Harada N, Okamura H, Misugi T, Suekane T, et al. Salvage Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplant With Posttransplant Cyclophosphamide for Graft Failure in a Patient With Chronic Active Epstein-Barr Virus Infection. Experimental and Clinical Transplantation. 2023. doi:10.6002/ect.2022.0322

BibTeX
@article{Nakaya2023,
  author = {Nakaya, Yosuke and Koh, Hideo and Harada, Naonori and Okamura, Hiroshi and Misugi, Takuya and Suekane, Tomoki and Tachibana, Daisuke and Kimura, Hiroshi and Hino, Masayuki and Nakamae, Hirohisa},
  title = {Salvage Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplant With Posttransplant Cyclophosphamide for Graft Failure in a Patient With Chronic Active Epstein-Barr Virus Infection},
  journal = {Experimental and Clinical Transplantation},
  year = {2023},
  doi = {10.6002/ect.2022.0322}
}
Start for free →